Farallon Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-222,979
Closed -$41.9M 324
2022
Q1
$41.9M Buy
222,979
+86,734
+64% +$16.5M 0.2% 77
2021
Q4
$36.1M Buy
136,245
+45,175
+50% +$12.2M 0.18% 75
2021
Q3
$26.3M Buy
+91,070
New +$23.4M 0.12% 90

Other funds holding RGEN

Farallon Capital Management's RGEN Position: Q2 2022 in Review

Farallon Capital Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 222,979 shares — an estimated $41.9M sold.

Farallon Capital Management first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $41.9M in Q1 2022. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Farallon Capital Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Farallon Capital Management sold 222,979 Repligen shares in Q2 2022, an estimated $41.9M.
  • Farallon Capital Management first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
  • Farallon Capital Management's Repligen position peaked at $41.9M in Q1 2022.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.